best marker to differentiate complicated from uncomplicated parapneumonic effusions, with a sensitivity of 94.1% and a specificity of 77.8% at a cut-off point of 1.32 (AUC = 0.887). Conclusions: Pleural fluid MMP-2, MMP-8 and MMP-9 may provide useful information for differentiating between uncomplicated and complicated parapneumonic effusions.
Parapneumonic pleural effusions (PPEs) -i.e. effusions secondary to pneumonia -most frequently are constituted by sterile reactive fluid and resolve with appropriate antibiotic therapy (uncomplicated parapneumonic pleural effusions, UPPEs) [19, 20] . However, in some cases, the pleural fluid gets infected, with resultant escalating intrapleural inflammation and fibrosis leading to the formation of adhesions and pleural fluid loculations. In these cases, invasive treatment such as pleural drainage and sometimes surgery is required, and the effusions are called complicated parapneumonic pleural effusions (CPPEs). If a CPPE is not appropriately treated, it will most probably evolve into pleural empyema [21, 22] . The differentiation between UPPE and CPPE is of critical importance, because it influences therapeutic decisions that affect patient outcomes [21] . For many years the classic biochemical parameters of the pleural fluid were considered to be the most useful indexes for identifying CPPE, and pH is the most widely used guide to indicate the need for pleural drainage in this condition [21, [23] [24] [25] . Despite these classification tools, the diagnosis of CPPE is still delayed in some patients.
MMPs are interesting candidate markers, since they have been implicated in the escalation of fibrosis and remodeling which are central to the subsequent progression of a PPE to empyema [26] . A previous study showed that empyemas or CPPE contain higher concentrations of MMP-1, MMP-8 and MMP-9 compared to other exudates and UPPE [14] . However, in this study the possible discriminative ability of MMP levels was not evaluated.
The aim of the present study was to evaluate the levels of MMP-2, MMP-8 and MMP-9 in the pleural fluid and serum of patients with pleural effusions. We also examined whether MMP-2, MMP-8 and MMP-9 could serve as independent markers for the differentiation between CPPE and UPPE.
Materials and Methods

Study Group
This study was performed on patients who were hospitalized in the Respiratory Medicine Department of the Medical School of the University of Thessaly in Larissa between September 2005 and November 2008. We stored pleural fluid and serum samples and recorded their clinical and laboratory data. For the purpose of the study, 208 consecutive patients who had undergone diagnostic thoracentesis for pleural effusions were studied ( table 1 ) . Seventyeight of these patients had been included in another study of our department [27] . It has to be stressed that the identification of an empyema led in all cases to the insertion of a thoracic tube [30] . (4) The diagnosis of congestive heart failure was based on the findings of an enlarged heart and/or pulmonary venous congestion on a chest radiograph, evidence of left ventricular systolic or diastolic dysfunction on echocardiography, and/or response to treatment for congestive heart failure. Classification of effusions was made by two experienced clinicians (K.K. and K.I.G.) blinded to the measurements of MMP-2, MMP-8 and MMP-9 at the time of the diagnosis. The characterization of effusions as exudates was further validated using the criteria of Light et al. [31] . Parapneumonic, tuberculous and malignant effusions were exudates, whereas effusions due to congestive heart failure were transudates. The study protocol was approved by the local ethics committee and all subjects provided written informed consent.
Specimen Collection and Processing
Pleural fluid samples were collected with the first successful thoracentesis before treatment. Simultaneously, 10 ml of venous blood were obtained. Samples were immediately analyzed by standard methods for total and differential cell counts (Gen S, Beckman Coulter), glucose, total protein and LDH (Olympus AU 600). Aliquots of pleural fluid and serum samples were immediately centrifuged at 1,500 g for 15 min at 4 ° C to pellet the cellular elements, and the supernatants were stored at -80 ° C for MMP-2, MMP-8 and MMP-9 measurements.
Enzyme Immunoassay
The immunoreactive levels of MMP-2, MMP-8 and MMP-9 were determined in the supernatants of pleural effusions utilizing sandwich enzyme immunoassays (R&D Systems, Minneapolis, Minn., USA).
Statistical Analysis
Normally distributed data are presented as means 8 SD and skewed data are presented as the median, 25th and 75th quartiles. The normality of distribution was checked with a Shapiro-Wilks test. Comparison among groups was performed using analysis of variance (ANOVA) on ranks (Kruskal-Wallis) with post-hoc pairwise testing (Dunn's method). Differences were regarded as statistically significant at p ! 0.05. To evaluate the usefulness of MMP-2, MMP-8 and MMP-9 levels in differentiating between UPPE and CPPE, receiver operator characteristic (ROC) analysis was performed, and the area under the curve (AUC) was calculated. The optimum cut-off point from ROC analysis was established by selecting the value that provides the greatest sum of sensitivity and specificity, i.e. the point closest to the upper left corner of the ROC plot. For the optimum cut-off point provided by each ROC analysis, sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value were calculated using standard formulas. Statistical analysis was performed using MedCalc 9.0 (MedCalc, Mariakerke, Belgium) and GraphPad Prism 5.0 software (GraphPad Software, San Diego, Calif., USA).
Results
General Characteristics of Pleural Effusions
The demographic data and the pleural fluid characteristics of the 208 patients that were included in the study are presented in table 1 .
Pleural fluid MMP-2 levels were higher in malignant pleural effusions than in transudative, tuberculous and parapneumonic effusions. Patients with infectious diseases (tuberculous and, especially, parapneumonic effusions) were characterized by higher pleural fluid and serum MMP-8 and MMP-9 levels and pleural fluid/serum MMP-8 and MMP-9 ratios, while the lowest values were observed in patients with transudates ( table 2 ) .
MMP-2, MMP-8 and MMP-9 in Parapneumonic Pleural Effusions
The levels of MMP-2, MMP-8 and MMP-9 in pleural fluid, serum and pleural fluid to serum ratio of patients with UPPE, CPPE or empyema are presented in table 3 .
The pleural fluid concentration of MMP-2 was significantly higher in patients with UPPE than in those with CPPE (p ! 0.01) or empyema (p ! 0.01). Pleural fluid MMP-8 levels were significantly higher in CPPE or empyema than in UPPE (p ! 0.01 and p ! 0.0001, respec-tively; table 3 , fig. 1 ). No significant differences were observed in serum MMP-2 and MMP-8 levels between UPPE, CPPE and empyema. Pleural fluid MMP-9 levels were significantly higher in empyema compared to UPPE (p ! 0.0001) and in CPPE compared to UPPE (p ! 0.01), while the serum levels were significantly higher in patients with CPPE than in those with UPPE (p ! 0.05; table 3 , fig. 1 ).
Diagnostic Performance for Differentiating UPPE and CPPE
The diagnostic performance of pleural fluid MMP-2, MMP-8 and MMP-9 according to the ROC analysis is presented in table 4 . Pleural fluid concentrations were more useful than serum concentrations or the pleural fluid/serum ratios in discriminating between UPPE and CPPE (data not presented). A low MMP-2 and a high MMP-9 pleural fluid content are almost equally effective in differentiating CPPE from UPPE, while MMP-8 was marginally inferior, as indicated by the AUCs. The combination of low MMP-2 with high MMP-8 or high MMP-9 slightly improved the performance of the single measurements. Notably, a MMP-2/MMP-9 ratio 1 1.32 represents the strongest predictor against a complicated parapneumonic effusion with a negative likelihood ratio of 0.08.
Discussion
In the present study, MMP-2, MMP-8 and MMP-9 were measured in the pleural fluid and serum of patients with pleural effusions. Our main findings are: (1) the highest pleural fluid and serum MMP-8 and MMP-9 levels are in patients with PPE; (2) pleural fluid levels of MMP-8 and MMP-9 are increased in CPPE and empyemas compared to UPPE, while pleural fluid MMP-2 levels are decreased in CPPE and empyemas compared to UPPE; (3) MMP-2 and MMP-9 measurements in the pleural fluid performed equally for the differentiation between UPPE and CPPE, whereas MMP-2/MMP-9 provided the best performance for the differentiation between UPPE and CPPE. Our data suggest that measurements of these two MMPs in pleural fluid may be helpful for the differentiation between UPPE and CPPE.
Several previous reports demonstrated the presence and enzymatic activities of these MMPs in pleural effusions of different origin, suggesting that these enzymes may play a role in the homeostasis of pleural space and are induced in specific disease states [12, 13, 15] . Iglesias et al. [14] showed that empyemas or CPPE contain significantly higher concentrations of MMP-8 and MMP-9 as compared to other exudates and UPPE. Our results are in agreement with the above findings, as the levels of MMP-8 and MMP-9 were highest in CPPE followed by UPPE. Table 3 shows that MMP-8 is 10-fold higher in CPPE as compared to UPPE and that MMP-9 is 20-fold higher in CPPE as compared to UPPE. Furthermore, we demonstrated that patients with empyema were characterized by the highest pleural fluid/serum MMP-9 ratios which, in contrast to those with other diagnoses, were 1 1, suggesting local production in the pleural cavity. These findings may be explained by the intense neutrophilic response observed in the empyema, since MMP-8 and MMP-9 are stored in the neutrophil granules [14] . On the other hand, the constant presence of MMP-2 in pleural effusions should be more likely attributed to constitutive MMP-2 expression by mesothelial cells and the fact that, + LR = Positive likelihood ratio; -LR = negative likelihood ratio; PPV = positive predictive value; NPV = negative predictive value; AUC = area under the curve; CI = confidence intervals. in contrast to MMP-9, inflammatory stimuli do not affect MMP-2 expression by mesothelial cells [32, 33] . These observations indicate that MMP-8 and MMP-9 but not MMP-2 may participate in the escalation of the pleural inflammatory and fibrotic reaction in patients with advanced disease. Pleural fluid drainage is required in patients with pleural infection (empyema or CPPE), while antibiotic treatment is adequate for UPPE; that means that the differentiation between these patients is of major clinical importance. Patients with frank pus in their pleural cavity are easily recognized, and in all such patients the insertion of a thoracic tube is indicated. On the other hand, in order to discriminate between non-purulent UPPE and CPPE which often look alike, current guidelines suggest that the biochemical characteristics of the pleural fluid should be examined. In connection to this, a low pleural fluid pH ( ! 7.20), a low glucose ( ! 2.2 mmol/l) and a high LDH value ( 1 1,000 IU/l) usually indicate the need for drainage [23, 34] . A meta-analysis of these 3 biochemical indexes revealed that pleural fluid pH (AUC = 0.89) was slightly more effective in identifying non-purulent CPPE than pleural fluid glucose or LDH (AUC = 0.71) [35] . Porcel et al. [21] found a considerable overlap between the AUC values for pH (AUC = 0.78), glucose (AUC = 0.82) and LDH (AUC = 0.86), but there was a trend toward a better accuracy of the latter, mainly because of its superior sensitivity. As reported in this study, 12 of 22 patients (55%) with PPE who ultimately underwent drainage exhibited pleural pH and glucose levels >7.20 and >60 mg/dl, respectively.
Clinical judgment, including patient evaluation and information obtained from chest X-rays and CT scans, remains the cornerstone of treatment decisions in the management of parapneumonic effusions, including the insertion of chest tubes or surgical interventions. However, biomarkers that provide information for the development of complicated parapneumonic effusions or empyemas may provide additional information to the attending physician in order to facilitate treatment decisions. Several biochemical markers such as myeloperoxidase [36] , TNF-␣ [21] or C-reactive protein [37] have been proposed to assist decision-making regarding clinical management. In the present study we examined the diagnostic accuracy of MMPs for the differentiation between UPPE and CPPE. Pleural fluid MMP-2/MMP-9 ratio was the best marker to differentiate between the two types of PPE, with a sensitivity of 94.1% and a specificity of 77.8% at a cut-off point of 1.32 (AUC = 0.887). Notably, a MMP-2/MMP-9 ratio 1 1.32 is the strongest predictor against a CPPE with a negative likelihood ratio of 0.08. Additionally, we have shown that even single measurements of either one of these MMPs were characterized by a satisfactory diagnostic accuracy. In contrast, serum levels and pleural fluid/serum ratio of MMPs could not effectively discriminate between UPPE and CPPE. We could thus assume that pleural fluid but not serum levels of MMPs may be helpful in detecting pleural infection and guiding the decision to drain a PPE.
Our study has several limitations. Firstly, the definition of CPPE was based on the subjective clinician judgment to drain the pleural space, according to the British Thoracic Society guidelines [29] , a fact that may lead to misclassification of some patients with PPE. Another major limitation of the study presented here is the fact that the diagnostic performance of the markers under investigation could not be reliably compared with that of conventional markers, such as pleural fluid pH, glucose or LDH. Unfortunately this problem is intrinsic to the design of studies in which the clinician who makes the decision whether or not to drain a parapneumonic effusion has to be aware of the pleural fluid data. Under these circumstances, there is no doubt that a decision to drain is substantially affected by the values of the pleural fluid features. We do not believe that it is realistic to conduct a clinical study like the present one in which the clinician would be blinded to the pleural fluid features. A large prospective study may be conducted to answer whether pleural fluid markers can predict the clinical outcome (death, need for surgery, duration of hospital stay) more accurately than pH or glucose. Finally, a possible flaw of our study is the over-presentation of PPE in the study population. Despite the fact that our population was carefully selected and evaluated, this may result in an overestimation of the diagnostic values of MMPs and it is an additional reason for further validation of our results in a different, large cohort.
In conclusion, our findings suggest that increased levels of pleural fluid MMP-8 and MMP-9 and decreased levels of MMP-2 are features of pleural space infection in patients with PPE, and such measurements may be helpful in the differentiation between UPPE and CPPE. The pleural fluid content of the above MMPs along with imaging data and the clinical presentation of the individual patient may contribute in the early identification of CPPE that need to be drained. The findings of the present study require further validation in a large prospective study dealing with the treatment and outcome of unselected patients with PPE before MMPs become part of a clinically meaningful practice.
